Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/13/2023
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Cybersecurity ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
National Institute of Health (NIH) ,
Popular ,
Public Health ,
Public Health Emergency
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
3/7/2023
/ Controlled Substances ,
DEA ,
Department of Health and Human Services (HHS) ,
Electronic Prescribing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Telehealth ,
Telemedicine
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
2/20/2023
/ Abbreviated New Drug Application (ANDA) ,
Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Pharmaceutical Industry
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
2/13/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medical Devices ,
Medicare ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Emergency ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
12/26/2022
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Medical Devices ,
Medicare ,
Medicare Part B ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Popular ,
SAMHSA ,
Telehealth
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
10/10/2022
/ Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
HRSA ,
Medical Devices ,
National Institute of Health (NIH) ,
User Fees ,
Vaccinations
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
6/20/2022
/ Centers for Disease Control and Prevention (CDC) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
National Institute of Health (NIH) ,
OIG ,
Provider Relief Fund ,
Telehealth ,
Telemedicine
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/25/2022
/ American Rescue Plan Act of 2021 ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Final Guidance ,
Food and Drug Administration (FDA) ,
GAO ,
Health Care Providers ,
Information Reports ,
Long Term Care Facilities ,
Medicare ,
National Institute of Health (NIH) ,
Proposed Rules ,
Public Meetings
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
4/18/2022
/ Abbreviated New Drug Application (ANDA) ,
Advisory Board ,
CBO Report ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Final Guidance ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
HRSA ,
Information Reports ,
Medical Devices ,
National Institute of Health (NIH) ,
Popular ,
Prescription Drugs ,
Proposed Rules ,
Public Meetings ,
Public Policy
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
4/4/2022
/ Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Health Care Providers ,
Health Insurance ,
Healthcare Fraud ,
National Institute of Health (NIH) ,
Proposed Rules ,
Public Policy
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more
3/14/2022
/ American Rescue Plan Act of 2021 ,
Appropriations Bill ,
Centers for Disease Control and Prevention (CDC) ,
Congressional Investigations & Hearings ,
Department of Veterans Affairs ,
Events ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Facilities ,
Information Reports ,
National Institute of Health (NIH) ,
SAMHSA